- Home
- FDP vs CLDX Comparison
FDP vs CLDX Comparison
Compare FDP & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDP
- CLDX
- Stock Information
- Founded
- FDP 1886
- CLDX N/A
- Country
- FDP Cayman Islands
- CLDX United States
- Employees
- FDP N/A
- CLDX N/A
- Industry
- FDP Farming/Seeds/Milling
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FDP Consumer Staples
- CLDX Health Care
- Exchange
- FDP Nasdaq
- CLDX Nasdaq
- Market Cap
- FDP N/A
- CLDX 1.3B
- IPO Year
- FDP 1997
- CLDX 2008
- Fundamental
- Price
- FDP $31.07
- CLDX $16.85
- Analyst Decision
- FDP
- CLDX Buy
- Analyst Count
- FDP 0
- CLDX 8
- Target Price
- FDP N/A
- CLDX $54.29
- AVG Volume (30 Days)
- FDP 443.3K
- CLDX 767.1K
- Earning Date
- FDP 05-01-2025
- CLDX 05-05-2025
- Dividend Yield
- FDP 3.89%
- CLDX N/A
- EPS Growth
- FDP N/A
- CLDX N/A
- EPS
- FDP 2.96
- CLDX N/A
- Revenue
- FDP $4,280,200,000.00
- CLDX $7,020,000.00
- Revenue This Year
- FDP $2.80
- CLDX N/A
- Revenue Next Year
- FDP $2.55
- CLDX $27.01
- P/E Ratio
- FDP $10.42
- CLDX N/A
- Revenue Growth
- FDP N/A
- CLDX 1.99
- 52 Week Low
- FDP $21.23
- CLDX $16.75
- 52 Week High
- FDP $35.27
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- FDP 59.24
- CLDX 29.79
- Support Level
- FDP $29.00
- CLDX $19.48
- Resistance Level
- FDP $30.43
- CLDX $20.38
- Average True Range (ATR)
- FDP 0.65
- CLDX 1.03
- MACD
- FDP 0.16
- CLDX -0.17
- Stochastic Oscillator
- FDP 99.04
- CLDX 2.19
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.